{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T05:06:35Z","timestamp":1793941595668,"version":"4.8.0"},"reference-count":90,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002322","name":"CAPES","doi-asserted-by":"publisher","award":["88881.186830\/2018-01"],"award-info":[{"award-number":["88881.186830\/2018-01"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"FAPESP","doi-asserted-by":"publisher","award":["2014\/16182-3"],"award-info":[{"award-number":["2014\/16182-3"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"FAPESP","doi-asserted-by":"publisher","award":["2015\/18432-0"],"award-info":[{"award-number":["2015\/18432-0"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"FAPESP","doi-asserted-by":"publisher","award":["2015\/17286-0"],"award-info":[{"award-number":["2015\/17286-0"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"FAPESP","doi-asserted-by":"publisher","award":["2016\/04761-4"],"award-info":[{"award-number":["2016\/04761-4"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"FAPESP","doi-asserted-by":"publisher","award":["2011\/23236-4"],"award-info":[{"award-number":["2011\/23236-4"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"FAPESP","doi-asserted-by":"publisher","award":["2015\/16714-8"],"award-info":[{"award-number":["2015\/16714-8"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"publisher","award":["302883\/2017-7"],"award-info":[{"award-number":["302883\/2017-7"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"publisher","award":["307155\/2017-0"],"award-info":[{"award-number":["307155\/2017-0"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004040","name":"KU Leuven","doi-asserted-by":"publisher","award":["PDM\/19\/164"],"award-info":[{"award-number":["PDM\/19\/164"]}],"id":[{"id":"10.13039\/501100004040","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004040","name":"KU Leuven","doi-asserted-by":"publisher","award":["CELSA 17\/047"],"award-info":[{"award-number":["CELSA 17\/047"]}],"id":[{"id":"10.13039\/501100004040","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"FWO","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011878","name":"Vlaamse regering","doi-asserted-by":"publisher","award":["GOA4919N"],"award-info":[{"award-number":["GOA4919N"]}],"id":[{"id":"10.13039\/501100011878","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011878","name":"Vlaamse regering","doi-asserted-by":"publisher","award":["GOE7120N"],"award-info":[{"award-number":["GOE7120N"]}],"id":[{"id":"10.13039\/501100011878","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011878","name":"Vlaamse regering","doi-asserted-by":"publisher","award":["GOC2319N"],"award-info":[{"award-number":["GOC2319N"]}],"id":[{"id":"10.13039\/501100011878","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.ijbiomac.2021.09.004","type":"journal-article","created":{"date-parts":[[2021,9,7]],"date-time":"2021-09-07T01:42:47Z","timestamp":1630978967000},"page":"564-573","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Towards toxin PEGylation: The example of rCollinein-1, a snake venom thrombin-like enzyme, as a PEGylated biopharmaceutical prototype"],"prefix":"10.1016","volume":"190","author":[{"given":"Ernesto Lopes","family":"Pinheiro-Junior","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johara","family":"Boldrini-Fran\u00e7a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnes Alessandra Sekijima","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T\u00e1ssia Rafaella","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"Peigneur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iara Aim\u00ea","family":"Cardoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isadora Sousa de","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suely Vilela","family":"Sampaio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos Roberto","family":"de Mattos Fontes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Tytgat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliane Candiani","family":"Arantes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2021.09.004_bb0005","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.3389\/fphar.2020.01132","article-title":"From animal poisons and venoms to medicines: achievements, challenges and perspectives in drug discovery","volume":"11","author":"Bordon","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"15","key":"10.1016\/j.ijbiomac.2021.09.004_bb0010","doi-asserted-by":"crossref","first-page":"6319","DOI":"10.1007\/s00253-018-9122-2","article-title":"Microbial production of toxins from the scorpion venom: properties and applications","volume":"102","author":"Amorim","year":"2018","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.ijbiomac.2021.09.004_bb0015","doi-asserted-by":"crossref","DOI":"10.1590\/s2175-97902018000001009","article-title":"Protein PEGylation for the design of biobetters: from reaction to purification processes","volume":"54","author":"Santos","year":"2018","journal-title":"Braz. J. Pharm. Sci."},{"key":"10.1016\/j.ijbiomac.2021.09.004_bb0020","series-title":"Handbook of Proteolytic Enzymes","article-title":"Introduction: serine peptidases and their clans","author":"Halfon","year":"1998"},{"issue":"8","key":"10.1016\/j.ijbiomac.2021.09.004_bb0025","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.toxicon.2005.02.020","article-title":"Snake venom serine proteinases: sequence homology vs. substrate specificity, a paradox to be solved","volume":"45","author":"Serrano","year":"2005","journal-title":"Toxicon"},{"key":"10.1016\/j.ijbiomac.2021.09.004_bb0030","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.toxicon.2015.04.005","article-title":"The structure-function relationship of thrombin-like enzymes from the green pit viper (Trimeresurus albolabris)","volume":"100","author":"Pradniwat","year":"2015","journal-title":"Toxicon"},{"issue":"3","key":"10.1016\/j.ijbiomac.2021.09.004_bb0035","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/0268-960X(93)90004-N","article-title":"Action of snake venom components on the haemostatic system","volume":"7","author":"Hutton","year":"1993","journal-title":"Blood Rev."},{"key":"10.1016\/j.ijbiomac.2021.09.004_bb0040","series-title":"Handbook of Venoms and Toxins of Reptiles","author":"Mackessy","year":"2010"},{"issue":"3","key":"10.1016\/j.ijbiomac.2021.09.004_bb0045","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1538-7836.2009.03701.x","article-title":"Direct fibrinolytic agents: biochemical attributes, preclinical foundation and clinical potential","volume":"8","author":"Marder","year":"2010","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.ijbiomac.2021.09.004_bb0050","article-title":"Functional and biological insights of rCollinein-1, a recombinant serine protease from Crotalus durissus collilineatus","volume":"25","author":"Boldrini-Franca","year":"2019","journal-title":"J. Venom. Anim. Incl. Trop. Dis."},{"issue":"23","key":"10.1016\/j.ijbiomac.2021.09.004_bb0055","doi-asserted-by":"crossref","first-page":"9971","DOI":"10.1007\/s00253-015-6836-2","article-title":"Expression of a new serine protease from Crotalus durissus collilineatus venom in Pichia pastoris and functional comparison with the native enzyme","volume":"99","author":"Boldrini-Franca","year":"2015","journal-title":"Appl. Microbiol. Biotechnol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2021.09.004_bb0060","doi-asserted-by":"crossref","first-page":"4476","DOI":"10.1038\/s41598-020-61258-x","article-title":"Beyond hemostasis: a snake venom serine protease with potassium channel blocking and potential antitumor activities","volume":"10","author":"Boldrini-Fran\u00e7a","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2021.09.004_bb0065","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.cbpa.2016.08.006","article-title":"How PEGylation influences protein conformational stability","volume":"34","author":"Lawrence","year":"2016","journal-title":"Curr. Opin. Chem. Biol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2021.09.004_bb0070","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s13346-019-00631-4","article-title":"PEGylation: a promising strategy to overcome challenges to cancer-targeted nanomedicines: a review of challenges to clinical transition and promising resolution","volume":"9","author":"Hussain","year":"2019","journal-title":"Drug Deliv. Transl. Res."},{"issue":"3","key":"10.1016\/j.ijbiomac.2021.09.004_bb0075","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nrd1033","article-title":"Effect of pegylation on pharmaceuticals","volume":"2","author":"Harris","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"issue":"2","key":"10.1016\/j.ijbiomac.2021.09.004_bb0080","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/d41573-020-00001-7","article-title":"2019 FDA drug approvals","volume":"19","author":"Mullard","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"issue":"2","key":"10.1016\/j.ijbiomac.2021.09.004_bb0085","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1021\/acs.bioconjchem.6b00565","article-title":"PEGylation enhances mosquito-larvicidal activity of Lysinibacillus sphaericus binary toxin","volume":"28","author":"Sharma","year":"2017","journal-title":"Bioconjug. Chem."},{"issue":"16","key":"10.1016\/j.ijbiomac.2021.09.004_bb0090","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.4155\/fmc.14.125","article-title":"PEGylation and its impact on the design of new protein-based medicines","volume":"6","author":"Ginn","year":"2014","journal-title":"Future Med. Chem."},{"issue":"2","key":"10.1016\/j.ijbiomac.2021.09.004_bb0095","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.xphs.2015.11.015","article-title":"PEGylation of biopharmaceuticals: a review of chemistry and nonclinical safety information of approved drugs","volume":"105","author":"Turecek","year":"2016","journal-title":"J. Pharm. Sci."},{"issue":"5","key":"10.1016\/j.ijbiomac.2021.09.004_bb0100","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0142-9612(00)00193-9","article-title":"Peptide and protein PEGylation: a review of problems and solutions","volume":"22","author":"Veronese","year":"2001","journal-title":"Biomaterials"},{"issue":"5","key":"10.1016\/j.ijbiomac.2021.09.004_bb0105","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2165\/00063030-200822050-00004","article-title":"The impact of PEGylation on biological therapies","volume":"22","author":"Veronese","year":"2008","journal-title":"BioDrugs"},{"issue":"3","key":"10.1016\/j.ijbiomac.2021.09.004_bb0110","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s12079-018-0492-0","article-title":"Protein PEGylation for cancer therapy: bench to bedside","volume":"13","author":"Gupta","year":"2019","journal-title":"J. Cell Commun. Signal"},{"issue":"12","key":"10.1016\/j.ijbiomac.2021.09.004_bb0115","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.2174\/0929866522666151013130742","article-title":"PEGylation: a successful approach to improve the biopharmaceutical potential of snake venom thrombin-like serine protease","volume":"22","author":"da-Silva-Freitas","year":"2015","journal-title":"Protein Pept. Lett."},{"issue":"5259","key":"10.1016\/j.ijbiomac.2021.09.004_bb0120","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/227680a0","article-title":"Cleavage of structural proteins during the assembly of the head of bacteriophage T4","volume":"227","author":"Laemmli","year":"1970","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.ijbiomac.2021.09.004_bb0125","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1038\/nprot.2007.321","article-title":"The use of differential scanning fluorimetry to detect ligand interactions that promote protein stability","volume":"2","author":"Niesen","year":"2007","journal-title":"Nat. Protoc."},{"issue":"9","key":"10.1016\/j.ijbiomac.2021.09.004_bb0130","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1038\/nprot.2007.321","article-title":"The use of differential scanning fluorimetry to detect ligand interactions that promote protein stability","volume":"2","author":"Niesen","year":"2007","journal-title":"Nat. Protoc."},{"issue":"W1","key":"10.1016\/j.ijbiomac.2021.09.004_bb0135","doi-asserted-by":"crossref","first-page":"W636","DOI":"10.1093\/nar\/gkz268","article-title":"The EMBL-EBI search and sequence analysis tools APIs in 2019","volume":"47","author":"Madeira","year":"2019","journal-title":"Nucleic Acids Res."},{"issue":"W1","key":"10.1016\/j.ijbiomac.2021.09.004_bb0140","doi-asserted-by":"crossref","first-page":"W296","DOI":"10.1093\/nar\/gky427","article-title":"SWISS-MODEL: homology modelling of protein structures and complexes","volume":"46","author":"Waterhouse","year":"2018","journal-title":"Nucleic Acids Res."},{"issue":"3","key":"10.1016\/j.ijbiomac.2021.09.004_bb0145","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1093\/bioinformatics\/btq662","article-title":"Toward the estimation of the absolute quality of individual protein structure models","volume":"27","author":"Benkert","year":"2011","journal-title":"Bioinformatics"},{"issue":"Web Server issue","key":"10.1016\/j.ijbiomac.2021.09.004_bb0150","article-title":"DICHROWEB, an online server for protein secondary structure analyses from circular dichroism spectroscopic data","volume":"32","author":"Whitmore","year":"2004","journal-title":"Nucleic Acids Research"},{"issue":"2","key":"10.1016\/j.ijbiomac.2021.09.004_bb0155","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1006\/abbi.2000.1958","article-title":"Structural and functional characterization of neuwiedase, a nonhemorrhagic fibrin(ogen)olytic metalloprotease from Bothrops neuwiedi snake venom","volume":"381","author":"Rodrigues","year":"2000","journal-title":"Arch. Biochem. Biophys."},{"issue":"5","key":"10.1016\/j.ijbiomac.2021.09.004_bb0160","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/0896-6273(92)90239-A","article-title":"Subunit stoichiometry of a mammalian K+ channel determined by construction of multimeric cDNAs","volume":"9","author":"Liman","year":"1992","journal-title":"Neuron"},{"issue":"1\u20132","key":"10.1016\/j.ijbiomac.2021.09.004_bb0165","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.ijbiomac.2021.09.004_bb0170","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1186\/1471-2105-8-238","article-title":"Prediction of MHC class II binding affinity using SMM-align, a novel stabilization matrix alignment method","volume":"8","author":"Nielsen","year":"2007","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.ijbiomac.2021.09.004_bb0175","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jprot.2018.02.020","article-title":"Global proteomic and functional analysis of Crotalus durissus collilineatus individual venom variation and its impact on envenoming","volume":"191","author":"Oliveira","year":"2019","journal-title":"J. Proteome"},{"issue":"1","key":"10.1016\/j.ijbiomac.2021.09.004_bb0180","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s12575-009-9008-x","article-title":"Size and shape of protein molecules at the nanometer level determined by sedimentation, gel filtration, and electron microscopy","volume":"11","author":"Erickson","year":"2009","journal-title":"Biol. Proced. Online"},{"issue":"12","key":"10.1016\/j.ijbiomac.2021.09.004_bb0185","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1016\/j.molimm.2007.10.016","article-title":"Computational characterization of B-cell epitopes","volume":"45","author":"Rubinstein","year":"2008","journal-title":"Mol. Immunol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2021.09.004_bb0190","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.intimp.2012.12.012","article-title":"The impact of PEGylation on protein immunogenicity","volume":"15","author":"Gefen","year":"2013","journal-title":"Int. Immunopharmacol."},{"issue":"1\u20132","key":"10.1016\/j.ijbiomac.2021.09.004_bb0195","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1089\/ten.tea.2013.0403","article-title":"Hyaluronidase-loaded PLGA microparticles as a new strategy for the treatment of pulmonary fibrosis","volume":"21","author":"da Silva Bitencourt","year":"2015","journal-title":"Tissue Eng. A"},{"key":"10.1016\/j.ijbiomac.2021.09.004_bb0200","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.procbio.2016.09.029","article-title":"Effect of protein immunogenicity and PEG size and branching on the anti-PEG immune response to PEGylated proteins","volume":"52","author":"Wan","year":"2017","journal-title":"Process Biochem."},{"issue":"2","key":"10.1016\/j.ijbiomac.2021.09.004_bb0205","doi-asserted-by":"crossref","DOI":"10.3390\/polym12020298","article-title":"The importance of Poly(ethylene glycol) alternatives for overcoming PEG immunogenicity in drug delivery and bioconjugation","volume":"12","author":"Hoang Thi","year":"2020","journal-title":"Polymers (Basel)"},{"issue":"3","key":"10.1016\/j.ijbiomac.2021.09.004_bb0210","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s00204-012-0957-5","article-title":"Crystal structure and activating effect on RyRs of AhV_TL-I, a glycosylated thrombin-like enzyme from Agkistrodon halys snake venom","volume":"87","author":"Zeng","year":"2013","journal-title":"Arch. Toxicol."},{"issue":"12","key":"10.1016\/j.ijbiomac.2021.09.004_bb0215","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1016\/j.biochi.2012.07.007","article-title":"Biochemical characterization and comparative analysis of two distinct serine proteases from Bothrops pirajai snake venom","volume":"94","author":"Menaldo","year":"2012","journal-title":"Biochimie"},{"issue":"2","key":"10.1016\/j.ijbiomac.2021.09.004_bb0220","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0086823","article-title":"The pro-coagulant fibrinogenolytic serine protease isoenzymes purified from Daboia russelii russelii venom coagulate the blood through factor V activation: role of glycosylation on enzymatic activity","volume":"9","author":"Mukherjee","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.ijbiomac.2021.09.004_bb0225","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.biochi.2007.10.005","article-title":"Molecular characterization of BjussuSP-I, a new thrombin-like enzyme with procoagulant and kallikrein-like activity isolated from Bothrops jararacussu snake venom","volume":"90","author":"Sant'Ana","year":"2008","journal-title":"Biochimie"},{"issue":"1","key":"10.1016\/j.ijbiomac.2021.09.004_bb0230","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.toxicon.2007.02.018","article-title":"BJ-48, a novel thrombin-like enzyme from the Bothrops jararacussu venom with high selectivity for arg over lys in P1: role of N-glycosylation in thermostability and active site accessibility","volume":"50","author":"Silva-Junior","year":"2007","journal-title":"Toxicon"},{"issue":"2","key":"10.1016\/j.ijbiomac.2021.09.004_bb0235","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.xphs.2015.11.015","article-title":"PEGylation of biopharmaceuticals: a review of chemistry and nonclinical safety information of approved drugs","volume":"105","author":"Turecek","year":"2016","journal-title":"J. Pharm. Sci."},{"issue":"20","key":"10.1016\/j.ijbiomac.2021.09.004_bb0240","doi-asserted-by":"crossref","first-page":"4591","DOI":"10.1021\/acs.jpcb.6b03097","article-title":"Light scattering analysis of mono- and multi-PEGylated bovine serum albumin in solution: role of composition on structure and interactions","volume":"120","author":"Ferebee","year":"2016","journal-title":"J. Phys. Chem. B"},{"issue":"5","key":"10.1016\/j.ijbiomac.2021.09.004_bb0245","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1021\/acs.molpharmaceut.6b00049","article-title":"Large-scale biophysical evaluation of protein PEGylation effects: in vitro properties of 61 protein entities","volume":"13","author":"Vernet","year":"2016","journal-title":"Mol. Pharm."},{"issue":"2\u20133","key":"10.1016\/j.ijbiomac.2021.09.004_bb0250","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.bpc.2007.11.002","article-title":"Structural characterization and low-resolution model of BJ-48, a thrombin-like enzyme from Bothrops jararacussu venom","volume":"132","author":"Guedes","year":"2008","journal-title":"Biophys. Chem."},{"issue":"11","key":"10.1016\/j.ijbiomac.2021.09.004_bb0255","doi-asserted-by":"crossref","first-page":"10524","DOI":"10.1074\/jbc.M412900200","article-title":"Crystal structures and amidolytic activities of two glycosylated snake venom serine proteinases","volume":"280","author":"Zhu","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.ijbiomac.2021.09.004_bb0260","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1055\/s-0037-1613834","article-title":"A novel fibrinogen-clotting enzyme, TL-BJ, from the venom of the snake Bothrops jararaca: purification and characterization","volume":"83","author":"Serrano","year":"2000","journal-title":"Thromb. Haemost."},{"issue":"14","key":"10.1016\/j.ijbiomac.2021.09.004_bb0265","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1021\/ac00038a021","article-title":"Conformational effects in the reversed-phase chromatographic behavior of recombinant human growth hormone (rhGH) and N-methionyl recombinant human growth hormone (Met-hGH)","volume":"64","author":"Oroszlan","year":"1992","journal-title":"Anal. Chem."},{"key":"10.1016\/j.ijbiomac.2021.09.004_bb0270","series-title":"Protein Denaturation in Nonlinear Isocratic and Gradient Elution Chromatography","first-page":"1067","volume":"40","author":"Whitley","year":"1994"},{"issue":"3","key":"10.1016\/j.ijbiomac.2021.09.004_bb0275","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/bit.10016","article-title":"Protein unfolding during reversed-phase chromatography: II. Role of salt type and ionic strength","volume":"76","author":"McNay","year":"2001","journal-title":"Biotechnol. Bioeng."},{"issue":"3","key":"10.1016\/j.ijbiomac.2021.09.004_bb0280","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/S0006-3495(03)74972-8","article-title":"Protein structure and dynamics in nonaqueous solvents: insights from molecular dynamics simulation studies","volume":"84","author":"Soares","year":"2003","journal-title":"Biophys. J."},{"issue":"2","key":"10.1016\/j.ijbiomac.2021.09.004_bb0285","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1529\/biophysj.104.041269","article-title":"Hydration of enzyme in nonaqueous media is consistent with solvent dependence of its activity","volume":"87","author":"Yang","year":"2004","journal-title":"Biophys. J."},{"issue":"7","key":"10.1016\/j.ijbiomac.2021.09.004_bb0290","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1023\/A:1016042220817","article-title":"Characterization and stability of N-terminally PEGylated rhG-CSF","volume":"13","author":"Kinstler","year":"1996","journal-title":"Pharm. Res."},{"issue":"1\u20132","key":"10.1016\/j.ijbiomac.2021.09.004_bb0295","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ijpharm.2010.03.036","article-title":"Biochemical and biophysical characterization of lysozyme modified by PEGylation","volume":"392","author":"Freitas Dda","year":"2010","journal-title":"Int. J. Pharm."},{"issue":"1\u20132","key":"10.1016\/j.ijbiomac.2021.09.004_bb0300","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ijpharm.2009.11.034","article-title":"Biochemical and biopharmaceutical properties of PEGylated uricase","volume":"387","author":"Freitas Dda","year":"2010","journal-title":"Int. J. Pharm."},{"issue":"10","key":"10.1016\/j.ijbiomac.2021.09.004_bb0305","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1111\/1440-1681.13134","article-title":"Biophysical and biological characterization of PEGylated recombinant human endostatin","volume":"46","author":"Guo","year":"2019","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.ijbiomac.2021.09.004_bb0310","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.foodres.2019.05.038","article-title":"Site specific PEGylation of beta-lactoglobulin at glutamine residues and its influence on conformation and antigenicity","volume":"123","author":"Luo","year":"2019","journal-title":"Food Res. Int."},{"issue":"4","key":"10.1016\/j.ijbiomac.2021.09.004_bb0315","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/0041-0101(93)90182-I","article-title":"Basic proteinases from Bothrops moojeni (caissaca) venom\u2013I. isolation and activity of two serine proteinases, MSP 1 and MSP 2, on synthetic substrates and on platelet aggregation","volume":"31","author":"Serrano","year":"1993","journal-title":"Toxicon"},{"issue":"8","key":"10.1016\/j.ijbiomac.2021.09.004_bb0320","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/S0041-0101(00)00261-0","article-title":"Purification and characterization of jerdofibrase, a serine protease from the venom of Trimeresurus jerdonii snake","volume":"39","author":"Jin","year":"2001","journal-title":"Toxicon"},{"issue":"17","key":"10.1016\/j.ijbiomac.2021.09.004_bb0325","doi-asserted-by":"crossref","first-page":"10246","DOI":"10.1074\/jbc.270.17.10246","article-title":"A novel plasminogen activator from snake venom. Purification, characterization, and molecular cloning","volume":"270","author":"Zhang","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2021.09.004_bb0330","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.clim.2017.03.014","article-title":"Prolonged immunomodulation in inflammatory arthritis using the selective Kv1.3 channel blocker HsTX1[R14A] and its PEGylated analog","volume":"180","author":"Tanner","year":"2017","journal-title":"Clin. Immunol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2021.09.004_bb0335","doi-asserted-by":"crossref","first-page":"491","DOI":"10.3390\/ijms17040491","article-title":"Pegylated trastuzumab fragments acquire an increased in vivo stability but show a largely reduced affinity for the target antigen","volume":"17","author":"Selis","year":"2016","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.ijbiomac.2021.09.004_bb0340","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0169-409X(02)00026-1","article-title":"PEGylated antibodies and antibody fragments for improved therapy: a review","volume":"54","author":"Chapman","year":"2002","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijbiomac.2021.09.004_bb0345","series-title":"Perspectives, Tendencies, and Guidelines in Affinity-based Strategies for the Recovery and Purification of PEGylated Proteins","author":"Mej\u00eda-Manzano","year":"2020"},{"key":"10.1016\/j.ijbiomac.2021.09.004_bb0350","doi-asserted-by":"crossref","DOI":"10.1186\/1477-7819-8-113","article-title":"Eag and HERG potassium channels as novel therapeutic targets in cancer","volume":"8","author":"Asher","year":"2010","journal-title":"World J. Surg. Oncol."},{"key":"10.1016\/j.ijbiomac.2021.09.004_bb0355","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1475-2867-11-6","article-title":"The role of Eag and HERG channels in cell proliferation and apoptotic cell death in SK-OV-3 ovarian cancer cell line","volume":"11","author":"Asher","year":"2011","journal-title":"Cancer Cell Int."},{"issue":"2","key":"10.1016\/j.ijbiomac.2021.09.004_bb0360","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2020.188355","article-title":"HERG channel and cancer: a mechanistic review of carcinogenic processes and therapeutic potential","volume":"1873","author":"He","year":"2020","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"issue":"6","key":"10.1016\/j.ijbiomac.2021.09.004_bb0365","doi-asserted-by":"crossref","first-page":"433","DOI":"10.21873\/cgp.20147","article-title":"MicroRNA 362\u20133p reduces hERG-related current and inhibits breast cancer cells proliferation","volume":"16","author":"Assiri","year":"2019","journal-title":"Cancer Genomics Proteomics"},{"issue":"2","key":"10.1016\/j.ijbiomac.2021.09.004_bb0370","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s00424-011-1045-z","article-title":"Inhibition of HERG1 K+ channel protein expression decreases cell proliferation of human small cell lung cancer cells","volume":"463","author":"Glassmeier","year":"2012","journal-title":"Pflugers Arch."},{"key":"10.1016\/j.ijbiomac.2021.09.004_bb0375","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/308475","article-title":"Effect of celastrol on growth inhibition of prostate cancer cells through the regulation of hERG channel in vitro","volume":"2015","author":"Ji","year":"2015","journal-title":"Biomed. Res. Int."},{"issue":"1","key":"10.1016\/j.ijbiomac.2021.09.004_bb0380","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1158\/1078-0432.CCR-16-2322","article-title":"hERG channels: from antitargets to novel targets for cancer therapy","volume":"23","author":"Arcangeli","year":"2017","journal-title":"Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.ijbiomac.2021.09.004_bb0385","doi-asserted-by":"crossref","first-page":"3476","DOI":"10.1016\/j.bbagen.2013.02.007","article-title":"Biochemical and pharmacological properties of a new thrombin-like serine protease (Russelobin) from the venom of Russell\u2019s viper (Daboia russelii russelii) and assessment of its therapeutic potential","volume":"1830","author":"Mukherjee","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ijbiomac.2021.09.004_bb0390","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.biochi.2014.04.002","article-title":"Characterization, mechanism of anticoagulant action, and assessment of therapeutic potential of a fibrinolytic serine protease (Brevithrombolase) purified from brevibacillus brevis strain FF02B","volume":"103","author":"Majumdar","year":"2014","journal-title":"Biochimie"},{"key":"10.1016\/j.ijbiomac.2021.09.004_bb0395","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.ijbiomac.2017.12.140","article-title":"The N-terminal-truncated recombinant fibrin(ogen)olytic serine protease improves its functional property, demonstrates in vivo anticoagulant and plasma defibrinogenation activity as well as pre-clinical safety in rodent model","volume":"111","author":"Bora","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2021.09.004_bb0400","doi-asserted-by":"crossref","first-page":"275","DOI":"10.4014\/jmb.1709.09075","article-title":"A novel thrombolytic and anticoagulant serine protease from Polychaeta, Diopatra sugokai","volume":"28","author":"Kim","year":"2018","journal-title":"J. Microbiol. Biotechnol."},{"key":"10.1016\/j.ijbiomac.2021.09.004_bb0405","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1159\/000478077","article-title":"The immunogenicity of biologic therapies","volume":"53","author":"Garces","year":"2018","journal-title":"Curr. Probl. Dermatol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2021.09.004_bb0410","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/imm.12213","article-title":"Discovery of protective B-cell epitopes for development of antimicrobial vaccines and antibody therapeutics","volume":"142","author":"Sharon","year":"2014","journal-title":"Immunology"},{"issue":"1","key":"10.1016\/j.ijbiomac.2021.09.004_bb0415","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/pro.2189","article-title":"Crystal structure of jararacussin-I: the highly negatively charged catalytic interface contributes to macromolecular selectivity in snake venom thrombin-like enzymes","volume":"22","author":"Ullah","year":"2013","journal-title":"Protein Sci."},{"key":"10.1016\/j.ijbiomac.2021.09.004_bb0420","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/6760830","article-title":"An introduction to B-cell epitope mapping and in silico epitope prediction","volume":"2016","author":"Potocnakova","year":"2016","journal-title":"J. Immunol. Res."},{"issue":"5","key":"10.1016\/j.ijbiomac.2021.09.004_bb0425","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/bjc.1996.99","article-title":"Polyethylene glycol modification of a galactosylated streptavidin clearing agent: effects on immunogenicity and clearance of a biotinylated anti-tumour antibody","volume":"73","author":"Marshall","year":"1996","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ijbiomac.2021.09.004_bb0430","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.procbio.2016.09.029","article-title":"Effect of protein immunogenicity and PEG size and branching on the anti-PEG immune response to PEGylated proteins","volume":"52","author":"Wan","year":"2017","journal-title":"Process Biochem."},{"key":"10.1016\/j.ijbiomac.2021.09.004_bb0435","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jconrel.2017.01.029","article-title":"Precise and combinatorial PEGylation generates a low-immunogenic and stable form of human growth hormone","volume":"249","author":"Wu","year":"2017","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.ijbiomac.2021.09.004_bb0440","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/s12934-017-0801-y","article-title":"Structure-based antigenic epitope and PEGylation improve the efficacy of staphylokinase","volume":"16","author":"Xu","year":"2017","journal-title":"Microb. Cell Factories"},{"key":"10.1016\/j.ijbiomac.2021.09.004_bb0445","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ejpb.2018.02.019","article-title":"A hydroxyl PEG version of PEGylated liposomes and its impact on anti-PEG IgM induction and on the accelerated clearance of PEGylated liposomes","volume":"127","author":"Shimizu","year":"2018","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijbiomac.2021.09.004_bb0450","first-page":"1","article-title":"Shielding effect of a PEG molecule of a mono-PEGylated peptide varies with PEG chain length","author":"Thi Nguyen","year":"2018","journal-title":"Prep. Biochem. Biotechnol."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813021019164?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813021019164?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T17:04:38Z","timestamp":1777482278000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813021019164"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":90,"alternative-id":["S0141813021019164"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2021.09.004","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Towards toxin PEGylation: The example of rCollinein-1, a snake venom thrombin-like enzyme, as a PEGylated biopharmaceutical prototype","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2021.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}